BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30516801)

  • 21. 3-dimensional volume rendered computerized tomography for preoperative evaluation and intraoperative treatment of patients undergoing nephron sparing surgery.
    Coll DM; Uzzo RG; Herts BR; Davros WJ; Wirth SL; Novick AC
    J Urol; 1999 Apr; 161(4):1097-102. PubMed ID: 10081846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional Variation of Computed Tomographic Imaging in the United States and the Risk of Nephrectomy.
    Welch HG; Skinner JS; Schroeck FR; Zhou W; Black WC
    JAMA Intern Med; 2018 Feb; 178(2):221-227. PubMed ID: 29279887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost comparison of nephron-sparing treatments for cT1a renal masses.
    Castle SM; Gorbatiy V; Avallone MA; Eldefrawy A; Caulton DE; Leveillee RJ
    Urol Oncol; 2013 Oct; 31(7):1327-32. PubMed ID: 22361086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial Nephrectomy for Presumed Renal-Cell Carcinoma: Incidence, Predictors, and Perioperative Outcomes of Benign Lesions.
    Bauman TM; Potretzke AM; Wright AJ; Knight BA; Vetter JM; Figenshau RS
    J Endourol; 2017 Apr; 31(4):412-417. PubMed ID: 28068796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can a Modified Bosniak Classification System Risk Stratify Pediatric Cystic Renal Masses?
    Saltzman AF; Carrasco A; Colvin AN; Meyers ML; Cost NG
    J Urol; 2018 Aug; 200(2):434-439. PubMed ID: 29572157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National trends and economic impact of surgical treatment for benign kidney tumors.
    Nguyen KA; Brito J; Hsiang W; Nolte A; Syed JS; Suarez-Sarmiento A; Leapman MS; Shuch B
    Urol Oncol; 2019 Mar; 37(3):183.e9-183.e15. PubMed ID: 30587401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between plasma Atherogenic index and final pathology of Bosniak III-IV renal masses: a retrospective, single-center study.
    Karabay E; Karsiyakali N; Duvar S; Tosun C; Aslan AR; Yucebas OE
    BMC Urol; 2019 Sep; 19(1):85. PubMed ID: 31519200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is Extensive Parenchymal Resection During Robotic Partial Nephrectomy Justified? A Match-Paired Comparison of Two Extirpative Surgical Modalities for Treatment of a Complex Renal Neoplasm.
    Andrade HS; Zargar H; Akca O; Caputo PA; Ramirez D; Kara O; Stein RJ; Chueh SC; Kaouk JH
    J Endourol; 2016 Apr; 30(4):379-83. PubMed ID: 26486995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of surveillance imaging following treatment of small renal masses.
    Kowalczyk KJ; Harbin AC; Choueiri TK; Hevelone ND; Lipsitz SR; Trinh QD; Tina Shih YC; Hu JC
    J Urol; 2013 Nov; 190(5):1680-5. PubMed ID: 23764074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National trends of preoperative imaging modalities before partial nephrectomy for renal masses in the U.S. from 2007-2015.
    Kim JH; Li S; Khandwala Y; Del Giudice F; Chung KJ; Park HK; Chung BI
    Can Urol Assoc J; 2019 Mar; 13(3):E89-E94. PubMed ID: 30169151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Declining incidence of benign lesions among small renal masses treated with surgery: Effect of diagnostic tests for characterization.
    Yoo S; You D; Song C; Hong B; Hong JH; Kim CS; Ahn H; Jeong IG
    Urol Oncol; 2018 Aug; 36(8):362.e9-362.e15. PubMed ID: 29866577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathology of surgically managed renal tumors: analysis of a contemporary series.
    Duchene DA; Lotan Y; Cadeddu JA; Sagalowsky AI; Koeneman KS
    Urology; 2003 Nov; 62(5):827-30. PubMed ID: 14624902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solitary solid renal mass: can we predict malignancy?
    Violette P; Abourbih S; Szymanski KM; Tanguay S; Aprikian A; Matthews K; Brimo F; Kassouf W
    BJU Int; 2012 Dec; 110(11 Pt B):E548-52. PubMed ID: 22612453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of malignancy in satellite renal lesions and its surgical implication during nephron sparing surgery.
    Raz O; Mendlovic S; Leibovici D; Pantuck AJ; Sandbank J; Sella A; Lindner A; Zisman A
    J Urol; 2007 Nov; 178(5):1892-5; discussion 1895. PubMed ID: 17868730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender disparity in kidney cancer treatment: women are more likely to undergo radical excision of a localized renal mass.
    O'Malley RL; Underwood W; Brewer KA; Hayn MH; Kim HL; Mehedint DC; Safwat MW; Huang WC; Schwaab T
    Urology; 2013 Nov; 82(5):1065-9. PubMed ID: 24358483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative imaging in renal cell cancer.
    Heidenreich A; Ravery V;
    World J Urol; 2004 Nov; 22(5):307-15. PubMed ID: 15290202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Core needle biopsy clarify the histology of the small renal masses and may prevent overtreatment.
    Azawi NH; Tolouee SA; Madsen M; Berg KD; Dahl C; Fode M
    Int Urol Nephrol; 2018 Jul; 50(7):1205-1209. PubMed ID: 29846890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic characteristics of solitary small renal masses: can they be predicted by preoperative clinical parameters?
    DeRoche T; Walker E; Magi-Galluzzi C; Zhou M
    Am J Clin Pathol; 2008 Oct; 130(4):560-4. PubMed ID: 18794048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation.
    Silverman SG; Mortele KJ; Tuncali K; Jinzaki M; Cibas ES
    Radiographics; 2007; 27(4):1131-43. PubMed ID: 17620471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.